liu.seSök publikationer i DiVA
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Biological treatment of ankylosing spondylitis: a nationwide study of treatment trajectories on a patient level in clinical practice
Karolinska Inst, Sweden.
Lund Univ, Sweden.
Karolinska Inst, Sweden.
Region Östergötland, Hjärt- och Medicincentrum, Reumatologiska kliniken i Östergötland.
Visa övriga samt affilieringar
2019 (Engelska)Ingår i: Arthritis Research & Therapy, ISSN 1478-6354, E-ISSN 1478-6362, Vol. 21, artikel-id 128Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

BackgroundThere is substantial evidence that patients with ankylosing spondylitis (AS) have high response rates to tumour necrosis factor inhibitors (TNFi), a low likelihood of successful treatment termination, but yet a limited drug retention. Whereas several reports have assessed drug retention rates for TNFi in AS, there are few, if any, studies investigating the actual treatment trajectories on a patient level, including subsequent therapy changes and dose reductions, of individual patients. The aim of this study was to describe 5-year treatment trajectories in patients with ankylosing spondylitis (AS) starting a first TNFi.MethodsBio-naive patients with AS starting a TNFi in 2006-2015 were identified in the nationwide Swedish Rheumatology Quality register and followed until 31 December 2015. All changes in their anti-rheumatic treatment during follow-up were recorded. To further increase precision, these data were complimented by information on the amount of prescribed subcutaneous TNFi collected from pharmacies during each year, retrieved from the Swedish Prescribed Drug Register.ResultsTwo thousand five hundred ninety patients started a first TNFi 2006-2015, and after 1year, 74% remained on their first TNFi. However, after 5years, this figure was only 46%, although at that time 63% were still on treatment with any biologic, while 30% had no anti-rheumatic treatment at all. After discontinuing the first TNFi, 46% switched directly to a second TNFi, but the drug retention for the second and third TNFi grew successively shorter compared to that for the first TNFi. In contrast, patients remaining on treatment with their first subcutaneous TNFi gradually reduced the dose, so that during the fifth year of treatment only 66% had collected 75% of the defined daily doses for that year.ConclusionLess than half of patients with AS will remain on their first TNFi after 5years, but most are still on a biologic. While patients remaining on treatment with their first TNFi appear to be able to reduce the dose over time, a large proportion cycle through several biologics, and 1/3 have no anti-rheumatic treatment after 5years. This indicates the importance of thorough follow-up programs as well as a need for alternative therapeutic options.

Ort, förlag, år, upplaga, sidor
BMC , 2019. Vol. 21, artikel-id 128
Nyckelord [en]
Ankylosing spondylitis; Tumour necrosis factor inhibitor; Treatment; Observational
Nationell ämneskategori
Reumatologi och inflammation
Identifikatorer
URN: urn:nbn:se:liu:diva-158328DOI: 10.1186/s13075-019-1908-9ISI: 000469446800001PubMedID: 31138285OAI: oai:DiVA.org:liu-158328DiVA, id: diva2:1333867
Anmärkning

Funding Agencies|Karolinska Institutet [NA]

Tillgänglig från: 2019-07-02 Skapad: 2019-07-02 Senast uppdaterad: 2019-07-02

Open Access i DiVA

Fulltext saknas i DiVA

Övriga länkar

Förlagets fulltextPubMed

Sök vidare i DiVA

Av författaren/redaktören
Qirjazo, Ilia
Av organisationen
Reumatologiska kliniken i Östergötland
I samma tidskrift
Arthritis Research & Therapy
Reumatologi och inflammation

Sök vidare utanför DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 7 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf